292 related articles for article (PubMed ID: 27552311)
1. Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.
Qiu H; Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2016 Aug; 21(8):88002. PubMed ID: 27552311
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
3.
Penjweini R; Kim MM; Ong YH; Zhu TC
Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy.
Sheng T; Ong YH; Guo W; Zhu T
J Biomed Opt; 2020 Jan; 25(6):1-13. PubMed ID: 31912689
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.
Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2017 Feb; 22(2):28002. PubMed ID: 28301655
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.
Penjweini R; Kim MM; Liu B; Zhu TC
J Biophotonics; 2016 Dec; 9(11-12):1344-1354. PubMed ID: 27653233
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species explicit dosimetry to predict local tumor control for Photofrin-mediated photodynamic therapy.
Sheng T; Ong YH; Busch TM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10860():. PubMed ID: 31327886
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species explicit dosimetry to predict local tumor growth for Photofrin-mediated photodynamic therapy.
Sheng T; Ong Y; Busch TM; Zhu TC
Biomed Opt Express; 2020 Aug; 11(8):4586-4601. PubMed ID: 32923066
[TBL] [Abstract][Full Text] [Related]
9. Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.
Wang KK; Finlay JC; Busch TM; Hahn SM; Zhu TC
J Biophotonics; 2010 Jun; 3(5-6):304-18. PubMed ID: 20222102
[TBL] [Abstract][Full Text] [Related]
10. Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
Penjweini R; Liu B; Kim MM; Zhu TC
J Biomed Opt; 2015; 20(12):128003. PubMed ID: 26720883
[TBL] [Abstract][Full Text] [Related]
11. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
Kim MM; Penjweini R; Liang X; Zhu TC
J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry study of PHOTOFRIN-mediated photodynamic therapy in a mouse tumor model.
Qiu H; Kim MM; Penjweini R; Zhu TC
Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27053822
[TBL] [Abstract][Full Text] [Related]
14. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
15. Reactive Oxygen Species Explicit Dosimetry for Photofrin-mediated Pleural Photodynamic Therapy.
Ong YH; Dimofte A; Kim MM; Finlay JC; Sheng T; Singhal S; Cengel KA; Yodh AG; Busch TM; Zhu TC
Photochem Photobiol; 2020 Mar; 96(2):340-348. PubMed ID: 31729774
[TBL] [Abstract][Full Text] [Related]
16. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species explicit dosimetry to predict tumor growth for BPD-mediated vascular photodynamic therapy.
Sheng T; Ong YH; Busch TM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10861():. PubMed ID: 31080306
[TBL] [Abstract][Full Text] [Related]
18. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
[TBL] [Abstract][Full Text] [Related]
19. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
20. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]